Brief: Epirus Biopharmaceuticals Q3 loss per share $1.28

Epirus Biopharmaceuticals

10/11/2014 21:30

Nov 10 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * Reports third quarter results and provides corporate update 
 * Q3 loss per share $1.28 
 * Says expect general and administrative expense to decrease in Q4 as compared 
   to the current period 
 
 * Source text for Eikon  ID:nBw8HY1rWa  
 
 * Further company coverage  EPRS.O  
  ((Bangalore Newsroom; +1 646 223 8780))